Onconetix Inc ONCO shares are trading sharply higher Thursday afternoon after the company highlighted a product milestone ...

REPL came under pressure after the FDA issued a second Complete Response Letter for RP1 with nivolumab in anti-PD-1-failed melanoma. ・HOTH declined after a $2 million stock offering, along with ...

On April 8, 2026, Realbotix announced that it has delivered its first Vinci-equipped humanoid robot to Ericsson. Vinci is a patented AI vision system that allows the robot to recognize returning users ...

Short interest in Realbotix Corp (OTC:XBOTF) increased during the last reporting period, rising from 240.92K to 257.36K. This put -% of the company's publicly available shares short. Short interest in ...

Welcome, everyone, to the Realbotix's Investor Call for 2024 to present our audited financial statements. On the call today is the management team, including myself, Andrew Kiguel, the CEO; Jennifer ...

(Nasdaq: ONCO) (“Onconetix” or the “Company”) today announced the appointment of David White as Chief Executive Officer, effective March 18, 2026, and the appointment of Sammy Dorf as a member of the ...

TORONTO--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robots and companionship-based AI, ...

Realbotix Corp. (TSX-V: XBOT | Frankfurt Stock Exchange: 76M0.F | OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robots and companionship-based AI, has received a payment of ...

TORONTO--(BUSINESS WIRE)-- Realbotix Corp. (TSX-V: XBOT | Frankfurt Stock Exchange: 76M | OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robots and companionship-based AI, ...

LAS VEGAS--(BUSINESS WIRE)-- Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robots and companionship-based ...